MedTrace Logo

Balloon Prophylaxis of Aneurysmal Vasospasm

NCT00282893 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2017-02-15

No results posted yet for this study

Summary

The purpose of this study is to determine if early transluminal ballooning of the major cerebral arteries prevents severe vasospasm and improves neurological outcome in patients with Fisher Grade III aneurysmal subarachnoid hemorrhage.

Conditions

  • Aneurysm
  • Vasospasm

Interventions

PROCEDURE

transluminal ballooning

OTHER

currently existing therapies for the treatment of vasospasm

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Jan Paul Muizelaar, MD, PhD · Professor and Chairman, Department of Neurological Surgery, University of California, Davis

  • Jonathan Hartman, MD · Interventional Neuroradiologist, University of California, Davis

  • Marike Zwienenberg, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2006-09-30
Completion
2006-12-31

Countries

  • United States
  • Canada
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282893 on ClinicalTrials.gov